Brief: Integragen Selected By SeqOIA GCS As Operator Of Its Sequencing Platform

IntegraGen SA

31/07/2018 07:14

July 31 (Reuters) - INTEGRAGEN SA  ALINT.PA :
    * THE SEQOIA COOPERATIVE HEALTH GROUP SELECTS INTEGRAGEN AS
THE
OPERATOR OF ITS SEQUENCING PLATFORM AS PART OF THE FRANCE
GENOMIC MEDICINE 2025 PLAN
    * INTEGRAGEN NOTED THAT THIS CONTRACT WILL AMOUNT TO EUR 18
MILLION OVER FIVE YEARS
    * THIS CONTRACT WILL PROVIDE SEQOIA GCS ACCESS TO DNA AND
RNA
SEQUENCING DATA FROM PATIENTS

Source text for Eikon:  ID:nBw39YlGka 
Further company coverage:  ALINT.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))